FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113168515> ?p ?o ?g. }

• W2113168515 endingPage "1130" @default.
• W2113168515 startingPage "1121" @default.
• W2113168515 abstract "Bcl-xL is an apoptosis inhibitor that is upregulated in bladder cancer (BCa) and provides an attractive target for molecular therapies. Treatment with specific antisense oligodeoxynucleotides (AS‑ODNs) or small interfering RNAs (siRNAs) were able to sensitize BCa cells to conventional chemotherapeutics. Ten new Bcl‑xL‑targeting AS‑ODNs were systematically designed by using predicting software. AS‑BX2034 and AS‑BX2100 as well as the previously optimized siRNA construct si‑BX713 were selected for further detailed in vitro analysis in the BCa cell lines UM‑UC‑3 and EJ28. Bcl‑xL mRNA and protein expression levels, cell viability and apoptosis were examined 72 h after transfection. A single treatment with AS‑BX2034 or AS‑BX2100 caused only a low inhibition of the Bcl‑xL mRNA expression with the highest reduction of ≤20% in UM‑UC‑3 cells. In contrast, a single treatment with si‑BX713 strongly decreased Bcl‑xL mRNA expression level by ≤69% in UM‑UC‑3 cells and by ≤86% in EJ28 cells. Both gene expression inhibitor types induced a low to moderate reduction of viability. Depending on the cell line, a combined treatment with AS‑BX2100 or si‑BX713 and cisplatin (CDDP) caused an additional inhibition of cell viability by ~33 and 38%, respectively, compared to the respective control construct combined with CDDP. In comparison to the respective control treatment, combinations of AS‑BX2100 and CDDP led to a stronger induction of apoptosis by 57% in UM‑UC‑3 cells and 44% in EJ28 cells, whereas the combination of si‑BX713 and CDDP enhanced apoptosis by 38 and 118% in UM‑UC‑3 and EJ28 cells, respectively. Our comparative studies showed a stronger knockdown of Bcl‑xL by the siRNA construct compared to AS‑ODN treatment in both BCa cell lines. In combinatory treatments, the Bcl‑xL-directed siRNA markedly enhanced the anti-proliferative and apoptotic effects of CDDP and therefore, may serve as suitable tool for chemosensitization of BCa cells." @default.
• W2113168515 created "2016-06-24" @default.
• W2113168515 creator A5006860769 @default.
• W2113168515 creator A5022786007 @default.
• W2113168515 creator A5039751847 @default.
• W2113168515 creator A5045437317 @default.
• W2113168515 creator A5065289402 @default.
• W2113168515 date "2015-07-20" @default.
• W2113168515 modified "2023-09-30" @default.
• W2113168515 title "Antisense- and siRNA-mediated inhibition of the anti-apoptotic gene Bcl-xL for chemosensitization of bladder cancer cells" @default.
• W2113168515 cites W1967857639 @default.
• W2113168515 cites W2014921813 @default.
• W2113168515 cites W2031399619 @default.
• W2113168515 cites W2034725151 @default.
• W2113168515 cites W2040406589 @default.
• W2113168515 cites W2050227906 @default.
• W2113168515 cites W2064559284 @default.
• W2113168515 cites W2066839011 @default.
• W2113168515 cites W2077177633 @default.
• W2113168515 cites W2077813812 @default.
• W2113168515 cites W2082597839 @default.
• W2113168515 cites W2083527153 @default.
• W2113168515 cites W2088883749 @default.
• W2113168515 cites W2114593293 @default.
• W2113168515 cites W2136361016 @default.
• W2113168515 cites W2143546230 @default.
• W2113168515 cites W2146888510 @default.
• W2113168515 cites W2151781453 @default.
• W2113168515 cites W2165592225 @default.
• W2113168515 cites W2170705825 @default.
• W2113168515 doi "https://doi.org/10.3892/ijo.2015.3096" @default.
• W2113168515 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26201840" @default.
• W2113168515 hasPublicationYear "2015" @default.
• W2113168515 type Work @default.
• W2113168515 sameAs 2113168515 @default.
• W2113168515 citedByCount "9" @default.
• W2113168515 countsByYear W21131685152016 @default.
• W2113168515 countsByYear W21131685152017 @default.
• W2113168515 countsByYear W21131685152021 @default.
• W2113168515 countsByYear W21131685152023 @default.
• W2113168515 crossrefType "journal-article" @default.
• W2113168515 hasAuthorship W2113168515A5006860769 @default.
• W2113168515 hasAuthorship W2113168515A5022786007 @default.
• W2113168515 hasAuthorship W2113168515A5039751847 @default.
• W2113168515 hasAuthorship W2113168515A5045437317 @default.
• W2113168515 hasAuthorship W2113168515A5065289402 @default.
• W2113168515 hasBestOaLocation W21131685151 @default.
• W2113168515 hasConcept C104317684 @default.
• W2113168515 hasConcept C119056186 @default.
• W2113168515 hasConcept C121608353 @default.
• W2113168515 hasConcept C1491633281 @default.
• W2113168515 hasConcept C153911025 @default.
• W2113168515 hasConcept C166703698 @default.
• W2113168515 hasConcept C190283241 @default.
• W2113168515 hasConcept C22615655 @default.
• W2113168515 hasConcept C2776694085 @default.
• W2113168515 hasConcept C2776789625 @default.
• W2113168515 hasConcept C2778239845 @default.
• W2113168515 hasConcept C2780352672 @default.
• W2113168515 hasConcept C2781018059 @default.
• W2113168515 hasConcept C29537977 @default.
• W2113168515 hasConcept C31573885 @default.
• W2113168515 hasConcept C502942594 @default.
• W2113168515 hasConcept C53227056 @default.
• W2113168515 hasConcept C54009773 @default.
• W2113168515 hasConcept C54355233 @default.
• W2113168515 hasConcept C55493867 @default.
• W2113168515 hasConcept C67705224 @default.
• W2113168515 hasConcept C81885089 @default.
• W2113168515 hasConcept C86803240 @default.
• W2113168515 hasConceptScore W2113168515C104317684 @default.
• W2113168515 hasConceptScore W2113168515C119056186 @default.
• W2113168515 hasConceptScore W2113168515C121608353 @default.
• W2113168515 hasConceptScore W2113168515C1491633281 @default.
• W2113168515 hasConceptScore W2113168515C153911025 @default.
• W2113168515 hasConceptScore W2113168515C166703698 @default.
• W2113168515 hasConceptScore W2113168515C190283241 @default.
• W2113168515 hasConceptScore W2113168515C22615655 @default.
• W2113168515 hasConceptScore W2113168515C2776694085 @default.
• W2113168515 hasConceptScore W2113168515C2776789625 @default.
• W2113168515 hasConceptScore W2113168515C2778239845 @default.
• W2113168515 hasConceptScore W2113168515C2780352672 @default.
• W2113168515 hasConceptScore W2113168515C2781018059 @default.
• W2113168515 hasConceptScore W2113168515C29537977 @default.
• W2113168515 hasConceptScore W2113168515C31573885 @default.
• W2113168515 hasConceptScore W2113168515C502942594 @default.
• W2113168515 hasConceptScore W2113168515C53227056 @default.
• W2113168515 hasConceptScore W2113168515C54009773 @default.
• W2113168515 hasConceptScore W2113168515C54355233 @default.
• W2113168515 hasConceptScore W2113168515C55493867 @default.
• W2113168515 hasConceptScore W2113168515C67705224 @default.
• W2113168515 hasConceptScore W2113168515C81885089 @default.
• W2113168515 hasConceptScore W2113168515C86803240 @default.
• W2113168515 hasIssue "3" @default.
• W2113168515 hasLocation W21131685151 @default.
• W2113168515 hasLocation W21131685152 @default.
• W2113168515 hasOpenAccess W2113168515 @default.
• W2113168515 hasPrimaryLocation W21131685151 @default.

• next